---
title: "Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Care management intervention strategies"
description: "Formulary evidence on Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Care management intervention strategies. Topics: Consensus guideline: multispecialty care coordinated through a primary care checklist, Consensus guideline: hospitalisation and anaesthesia precautions, Anaesthesia recommendation: postoperative respiratory care, Respiratory management: Italian Delphi consensus, and 4 further topics. 8 evidence topics quoted from 7 sources."
canonical: "https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description/care-management-intervention-strategies"
published: "2026-11-15T20:23:41-05:00"
modified: "2026-11-15T20:23:41-05:00"
---

# Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Care management intervention strategies

<a id="heading-2.2.2.4"></a>

## 2.2.2.4 Care Management Intervention Strategies

<a id="topic-2.2.2.4-1"></a>

### Consensus guideline: multispecialty care coordinated through a primary care checklist

> “Management of RTT requires input or expertise related to multiple specialties, often necessitating referrals to many providers in addition to the primary care provider.”
> “The checklist (table 1) is suitable for use by health professionals as well as the family as part of their healthcare records, with tables 2–6 providing further detailed guidance.”
> “Review available community and insurance resources (disabled parking permit, respite care and so on).”

Source: [Fu et al. (2020a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7488790/)

<a id="topic-2.2.2.4-2"></a>

### Consensus guideline: hospitalisation and anaesthesia precautions

> “Individuals may be more sensitive to effects of anaesthetics. They may take longer to awaken from anaesthesia. It is important to ensure anaesthesiologist is aware of current medications (especially anticonvulsants and cannabis preparations), type and description of seizures, breathing abnormalities, and risk of presence of prolonged QTc; a recent ECG is essential.”

Source: [Fu et al. (2020a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7488790/)

<a id="topic-2.2.2.4-3"></a>

### Anaesthesia recommendation: postoperative respiratory care

> “Regardless of the agents used, given the airway and respiratory co-morbid conditions seen in Rett syndrome, postoperative monitoring of respiratory function is recommended.”
> “Non-invasive respiratory support techniques such as BiPAP would facilitate postoperative tracheal extubation in these patients.”

Source: [Maheshwari (2018)](https://www.ai-online.info/images/ai-ausgabe/2018/04-2018/orphan-supplement-6-2018/2018_4_S117-S124_Rett%20syndrome.pdf)

<a id="topic-2.2.2.4-4"></a>

### Respiratory management: Italian Delphi consensus

> “Noninvasive ventilation should be considered in all RS subjects with sleep respiratory disorders and in those with hypotonia associated with hypercapnia.”
> “Chest physiotherapy should be performed in all RS patients with difficult management of the accumulation of respiratory secretions, using airway clearance techniques and devices (PEP-mask, AMBU bag, or cough machine), more appropriate and tolerated by the patients.”

Source: [Cherchi et al. (2024)](https://pubmed.ncbi.nlm.nih.gov/38721909/)

<a id="topic-2.2.2.4-5"></a>

### Multidisciplinary clinic model: 20 years at a pediatric tertiary hospital

> “The clinic has a diverse team of medical practitioners, including a Pediatrician, Clinical Geneticist and Dentist, along with Allied Health professionals such as a Genetic Counsellor, Dietitian, Physiotherapist, Occupational Therapist, Speech Therapist and a Music Therapist.”
> “The results of this study highlight the usefulness of our clinical model based on multidisciplinary management aimed at preserving and/or prolonging independence in mobility, feeding and communication.”

Source: [Vilvarajan et al. (2023)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10454341/)

<a id="topic-2.2.2.4-6"></a>

### Transition from paediatric to adult care

> “We have a formal programme for transition and transfer of care that takes into account external referrals and ensures continuity of care for those paediatric individuals who are already known to our staff.”
> “The delineation of an adult phenotype in Rett syndrome demonstrates the importance of a transitional programme and the need of a dedicated multidisciplinary team to optimise the clinical management of these patients.”

Source: [Peron et al. (2022)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8685662/)

<a id="topic-2.2.2.4-7"></a>

### Fragmented care: European caregiver study

> “87% of participants reported having to change their primary physician, with the most common reported reasons including dissatisfaction with care (15%), inadequate follow-up or coordination of care (15%), and evolving needs (17%) (Fig. 5e). Only 3% of RTT patients access a sleep specialist, despite sleep being a highly disruptive issue.”
> “Care was also reported to be geographically fragmented with only 3% of participants reporting that they received all their care at the same location”
> “The changing needs across the lifespan underscore the importance of anticipatory, multidisciplinary care models and improved transition pathways into adulthood.”

Source: [Pulles et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13721293/)

<a id="topic-2.2.2.4-8"></a>

### Caregiver education for trofinetide gastrointestinal adverse events

> “The nurse coordinators emphasized the importance of participant/caregiver education when introducing a new drug, and their experiences with the GI side effects of trofinetide in the LAVENDER trial informed their communications with the caregivers. A common theme is that, although there are some strategies for managing GI side effects that should be recommended initially (e.g., loperamide for diarrhea), each individual with RTT is unique and different methods may work better in some than others.”

Source: [Moore et al. (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10960750/)

## Related pages
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Terms and abbreviations](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations.md)
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Product information and disease description](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Clinical evidence](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Economic information and modeling report](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: References](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references.md)
